These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23791821)

  • 1. Thrombolysis with alteplase after stroke: extending outcomes.
    Anderson C
    Lancet Neurol; 2013 Aug; 12(8):731-2. PubMed ID: 23791821
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteplase for ischaemic stroke.
    Burrage D
    Lancet; 2014 Oct; 384(9953):1502. PubMed ID: 25390573
    [No Abstract]   [Full Text] [Related]  

  • 4. Alteplase for stroke. Uncertainty remains about efficacy.
    Mann H
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12089100
    [No Abstract]   [Full Text] [Related]  

  • 5. Alteplase for ischaemic stroke--responses.
    Hudson I
    Lancet; 2014 Aug; 384(9944):662-3. PubMed ID: 25152268
    [No Abstract]   [Full Text] [Related]  

  • 6. Alteplase for ischaemic stroke--responses.
    Wardlaw JM; Murray V; Berge E; Del Zoppo GJ
    Lancet; 2014 Aug; 384(9944):661-2. PubMed ID: 25152267
    [No Abstract]   [Full Text] [Related]  

  • 7. Tenecteplase versus alteplase for acute ischemic stroke.
    González RG
    N Engl J Med; 2012 Jul; 367(3):275-6; author reply 276. PubMed ID: 22808969
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel lytics, novel imaging: a new treatment strategy in stroke?
    Quinn TJ; Dawson J
    J Comp Eff Res; 2012 Jul; 1(4):311-4. PubMed ID: 24237464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteplase for stroke. Patients and doctors are being misled by promotional pressures.
    Li J; Nathanson LA; Mills TJ; Netland KE; Paula R; Ragland D
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092605
    [No Abstract]   [Full Text] [Related]  

  • 10. Alteplase for stroke. Why were these authors of the commentaries chosen?
    Hoffman JR
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092608
    [No Abstract]   [Full Text] [Related]  

  • 11. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type of the Canadian alteplase for stroke effectiveness study registry.
    Libman R; Kwiatkowski T
    Stroke; 2007 Sep; 38(9):e88. PubMed ID: 17673802
    [No Abstract]   [Full Text] [Related]  

  • 12. Alteplase for stroke. Financial information is needed to ensure objectivity.
    Solomon RC
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092607
    [No Abstract]   [Full Text] [Related]  

  • 13. Questions about authorisation of alteplase for ischaemic stroke.
    Shinton R
    Lancet; 2014 Aug; 384(9944):659-60. PubMed ID: 25152265
    [No Abstract]   [Full Text] [Related]  

  • 14. Stroke guideline supports expanded alteplase use.
    Traynor K
    Am J Health Syst Pharm; 2013 Mar; 70(6):474, 476, 478. PubMed ID: 23456396
    [No Abstract]   [Full Text] [Related]  

  • 15. Alteplase for ischaemic stroke--much sooner is much better.
    Saver JL; Levine SR
    Lancet; 2010 May; 375(9727):1667-8. PubMed ID: 20472152
    [No Abstract]   [Full Text] [Related]  

  • 16. Alteplase for acute stroke revisited: the first 10 years.
    Lyden PD; Lees KR; Davis SM
    Lancet Neurol; 2006 Sep; 5(9):722-4. PubMed ID: 16914399
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study].
    Di Pasquale G
    Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744
    [No Abstract]   [Full Text] [Related]  

  • 18. A panoramic, practice-based view of intravenous alteplase 3-4.5 h after stroke.
    Kasner SE; Levine SR
    Lancet Neurol; 2010 Sep; 9(9):843-5. PubMed ID: 20667791
    [No Abstract]   [Full Text] [Related]  

  • 19. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
    Aoki S; Hosomi N; Sueda Y; Kono T; Takamatsu K; Ohyama H; Torii T; Kitamura T; Nomura E; Noda K; Ohtsuki T; Matsumoto M;
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of thrombolysis for ischaemic stroke.
    Dirks M; Dippel DW
    Lancet Neurol; 2013 Feb; 12(2):120-1. PubMed ID: 23260190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.